Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

292 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combination antifungal therapy: where are we now, and where are we going?
Marr K. Marr K. Oncology (Williston Park). 2004 Nov;18(13 Suppl 7):24-9. Oncology (Williston Park). 2004. PMID: 15651179 Review.
Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.
Neofytos D, Railkar R, Mullane KM, Fredricks DN, Granwehr B, Marr KA, Almyroudis NG, Kontoyiannis DP, Maertens J, Fox R, Douglas C, Iannone R, Kauh E, Shire N. Neofytos D, et al. PLoS One. 2015 Jun 24;10(6):e0129022. doi: 10.1371/journal.pone.0129022. eCollection 2015. PLoS One. 2015. PMID: 26107507 Free PMC article. Clinical Trial.
Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
Ju JY, Polhamus C, Marr KA, Holland SM, Bennett JE. Ju JY, et al. Antimicrob Agents Chemother. 2002 May;46(5):1240-5. doi: 10.1128/aac.46.5.1240-1245.2002. Antimicrob Agents Chemother. 2002. PMID: 11959551 Free PMC article.
New methods to assess susceptibilities of Aspergillus isolates to caspofungin.
Imhof A, Balajee SA, Marr KA. Imhof A, et al. J Clin Microbiol. 2003 Dec;41(12):5683-8. doi: 10.1128/jcm.41.12.5683-5688.2003. J Clin Microbiol. 2003. PMID: 14662961 Free PMC article.
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Kontoyiannis DP, Ratanatharathorn V, Young JA, Raymond J, Laverdière M, Denning DW, Patterson TF, Facklam D, Kovanda L, Arnold L, Lau W, Buell D, Marr KA. Kontoyiannis DP, et al. Transpl Infect Dis. 2009 Feb;11(1):89-93. doi: 10.1111/j.1399-3062.2008.00349.x. Epub 2008 Oct 8. Transpl Infect Dis. 2009. PMID: 18983417 Clinical Trial.
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG. Baddley JW, et al. Med Mycol. 2013 Feb;51(2):128-35. doi: 10.3109/13693786.2012.690108. Epub 2012 Jun 11. Med Mycol. 2013. PMID: 22680976
Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, Pfaller MA, Weiss MA, Webster KM, Neofytos D. Horn DL, et al. Diagn Microbiol Infect Dis. 2007 Dec;59(4):407-14. doi: 10.1016/j.diagmicrobio.2007.06.008. Epub 2007 Sep 20. Diagn Microbiol Infect Dis. 2007. PMID: 17888614
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ, Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA, Queiroz-Telles F, Selleslag D, Walsh TJ, Wingard JR, Maertens JA. Marr KA, et al. Ann Intern Med. 2015 Jan 20;162(2):81-9. doi: 10.7326/M13-2508. Ann Intern Med. 2015. PMID: 25599346 Clinical Trial.
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.
Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C, Ullmann AJ, Seibel NL, Flynn PM, van Burik JA, Buell DN, Patterson TF. Denning DW, et al. J Infect. 2006 Nov;53(5):337-49. doi: 10.1016/j.jinf.2006.03.003. Epub 2006 May 6. J Infect. 2006. PMID: 16678903 Free PMC article. Clinical Trial.
292 results
Jump to page